Developmental Pharmacology and Toxicology: Role of Ontogeny (R01)

Funding Opportunity Announcement (FOA) Number	PAR-13-306
Companion Funding Opportunity	PAR-13-307, R03 Small Grant Program PAR-13-308, R21 Exploratory/Developmental Grant
Number of Applications	See Section III. 3. Additional Information on Eligibility.
Catalog of Federal Domestic Assistance (CFDA) Number(s)	93.865, 93.113, 93.869
Funding Opportunity Purpose	This Funding Opportunity Announcement (FOA) encourages grant applications from institutions or organizations that propose multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology and toxicology. Particular emphasis should be placed on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways across developmental periods from fetal life to adolescence affecting drug action and toxicity.

Key Dates

Posted Date	August 7, 2013
Open Date (Earliest Submission Date)	September 5, 2013
Letter of Intent Due Date(s)	30 days prior to the application due date
Application Due Date(s)	Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.